| Symbol | CNTB |
|---|---|
| Name | CONNECT BIOPHARMA HOLDINGS LTD |
| Sector | UNDEFINED |
| Region | UNDEFINED |
| Industry | Pharmaceutical Preparations |
| Address | 3580 CARMEL MOUNTAIN ROAD, SUITE 200, SAN DIEGO, CA 92130 |
| Telephone | 858-727-1040 |
| Fax | — |
| — | |
| Website | — |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001835268 |
| Description | None |
Connect Biopharma Announces Completion of Enrollment of Phase 2 Seabreeze STAT Asthma Study Evaluating Rademikibart for the Treatment of Acute Exacerbations in Asthma
Read moreHuang James 🟢 acquired 150.0K shares of Connect Biopharma Holdings Ltd (CNTB) at $2.48 Transaction Date: May 29, 2026 | Filing ID: 253607
Read moreNew Form EFFECT - Connect Biopharma Holdings Ltd <b>Filed:</b> 2026-06-01 <b>AccNo:</b> 9999999995-26-001825 <b>Size:</b> 1 KB
Read moreNew Form SCHEDULE 13G/A - Connect Biopharma Holdings Ltd <b>Filed:</b> 2026-05-15 <b>AccNo:</b> 0001913491-26-000003 <b>Size:</b> 6 KB
Read moreNew Form F-3 - Connect Biopharma Holdings Ltd <b>Filed:</b> 2026-05-15 <b>AccNo:</b> 0001193125-26-225436 <b>Size:</b> 488 KB
Read moreConnect Biopharma to Present at the H.C. Wainwright 4th Annual BioConnect Investor Conference
Read more(30% Negative) CONNECT BIOPHARMA HOLDINGS LTD (CNTB) Reports Q2 2026 Financial Results
Read moreConnect Biopharma Reports First Quarter 2026 Financial Results and Provides Business Update
Read more(90% Positive) CONNECT BIOPHARMA HOLDINGS LTD (CNTB) Announces Enrollment Update for care Due to Patient Enrollment Issues, Regulatory Process, Safety Review, Efficacy Assessment
Read moreNew Form SCHEDULE 13G - Connect Biopharma Holdings Ltd <b>Filed:</b> 2026-04-14 <b>AccNo:</b> 0001912836-26-000001 <b>Size:</b> 8 KB
Read more